phase ii clinical trial with vindesine for remission induction in acute leukemia , blastic crisis of chronic myeloid leukemia , lymphosarcoma , and hodgkin 's disease : absence of cross-resistance with vincristine .
C0024299
lymphosarcoma
C0019829
hodgkin 's disease